Omeros (OMER) Current Assets (2010 - 2026)
Omeros (OMER) posted Current Assets of $180.4 million for Q1 2026, down 16.37% sequentially from $215.7 million in Q4 2025, and up 87.52% YoY from $96.2 million in Q1 2025.
Omeros (OMER) Current Assets (2010 - 2026) Analysis & Trends
Omeros has reported Current Assets for 17 years, with the latest figure at $180.4 million in Q1 2026.
- Quarterly Current Assets rose 87.52% year-over-year to $180.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.4 million (up 87.52% YoY) and the FY2025 annual result came in at $215.7 million, up 60.8% from the prior year.
- Current Assets declined to $180.4 million in Q1 2026 per OMER's latest filing, from $215.7 million in the prior quarter.
- Over five years, Current Assets peaked at $443.2 million in Q4 2022 and troughed at $69.6 million in Q2 2025.
- A 5-year average of $230.9 million and a median of $210.2 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 215.87% in 2022, then plunged 65.77% in 2025.
- Over 5 years, Current Assets stood at $443.2 million in 2022, then tumbled by 50.84% to $217.9 million in 2023, then tumbled by 38.45% to $134.1 million in 2024, then jumped by 60.8% to $215.7 million in 2025, then dropped by 16.37% to $180.4 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $180.4 million, $215.7 million, and $71.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 185.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 185.24 Mn |
| Mar 31, 2026 | 180.36 Mn |
| Dec 31, 2025 | 215.67 Mn |
| Sep 30, 2025 | 71.81 Mn |
| Jun 30, 2025 | 69.65 Mn |
| Mar 31, 2025 | 96.18 Mn |
| Dec 31, 2024 | 134.12 Mn |
| Sep 30, 2024 | 164.92 Mn |
| Jun 30, 2024 | 202.93 Mn |
| Mar 31, 2024 | 280.96 Mn |
| Dec 31, 2023 | 217.90 Mn |
| Sep 30, 2023 | 351.34 Mn |
| Jun 30, 2023 | 388.56 Mn |
| Mar 31, 2023 | 417.04 Mn |
| Dec 31, 2022 | 443.24 Mn |
| Sep 30, 2022 | 288.55 Mn |
| Jun 30, 2022 | 192.72 Mn |
| Mar 31, 2022 | 210.22 Mn |
| Dec 31, 2021 | 247.96 Mn |
| Sep 30, 2021 | 91.35 Mn |